arrow
C

Christopher M. Hovens

University of Melbourne
H指数:61
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer

前列腺癌中基因组驱动突变的分子异质性与临床影响

2026-10-160
OAAI
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer

前列腺癌中双等位基因表观遗传失活的复发机制揭示了新的潜在肿瘤抑制基因

2026-09-090
OAAI
Integrated signatures define mutational processes in prostate cancer

整合特征定义前列腺癌中的突变过程

Nature
IF48.5
2026-09-090
OAAI
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer
2024-04-013
OA
Genomic evolution shapes prostate cancer disease type

基因组进化塑造前列腺癌疾病类型

2024-03-010
OAAI
Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol

硒酸钠作为慢性耐药性颞叶癫痫的疾病改善治疗的II期随机安慰剂对照试验: 选择研究方案

2023-10-271
OAAI
Ultra-sensitive detection of circulating tumour DNA enriches for patients with higher risk disease in clinically localised prostate cancer
2023-06-020
PRE
Germline structural variants shape prostate cancer clinical and molecular evolution
2023-04-041
PRE
A polygenic two-hit hypothesis for prostate cancer
2023-01-052
OA
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study

罕见种系变异与前列腺癌根治性治疗后快速生化复发相关: 一项泛前列腺癌组研究

2022-08-014
OA
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia

硒酸钠作为可能的行为变异额颞痴呆的疾病改善疗法的1b期开放标签研究

2022-05-059
OAAI
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
2021-11-0178
OAAI
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
2021-07-223
OAAI
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
2021-06-098
PREAI
Original Research Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival
2021-05-0117
PREAI